Determination of the oncogenes p53 and C-erb B2 in the tumour cytosols of advanced hepatocellular carcinoma (HCC) and correlation to survival time

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2501-2503

  Heinze, Thomas ^a   Jonas, Sven ^a   Karsten, Andreas ^a   Neuhaus, Peter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

C erb B2; Hepatocellular carcinoma (HCC); p53; Survival time

Indexed keywords

PROTEIN P53;

ADVANCED CANCER; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LIVER CELL CARCINOMA; LIVER CYTOSOL; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; CYTOSOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES, ERBB-2; GENES, P53; HEPATECTOMY; HUMANS; IMMUNOASSAY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LUMINESCENT MEASUREMENTS; PROGNOSIS; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032812847     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Lane DP, Crawford Lv: T-antigen is bound to a host protein in SV-40 transformed cells. Nature 278: 261-263, 1979.
2. Bartek J, Bartkova J, Vojtesek B et al: Patterns of expression of the p53 tumor suppressor in human breast tissues and tumors in situ and in vitro. Int J Cancer 46: 839-844, 1990.
3. Cattoretti G, Rilke Fk, Andreola S et al: p53 expression in breast cancer. Int J Cancer 41: 178-183, 1988.
4. Davidoff AM, Herndon, JE, Glover NS et al: Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery 110/2: 259-264, 1991.
5. Yamamoto T, Shantard I, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K: An erb-B-related gene c-erbB-2 encodes a possible receptor protein similar to the epidermal growth factor receptor. Nature 319: 230-234, 1986.
6. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987.
7. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712, 1989.
8. Tandon AK, Clark GM, Chamness GC, Ullrich A, McGuire WL: HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 7: 1120-1128, 1989.